(Q54311896)

English

Accuracy and Reproducibility of HER2 Status in Breast Cancer Using Immunohistochemistry: A Quality Control Study in Tuscany Evaluating the Impact of Updated 2013 ASCO/CAP Recommendations.

scientific article published on 4 November 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25367072%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Accuracy and Reproducibility of HER2 Status in Breast Cancer Using Immunohistochemistry: A Quality Control Study in Tuscany Evaluating the Impact of Updated 2013 ASCO/CAP Recommendations (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25367072%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

quality control

0 references

immunohistochemistry

1 reference

based on heuristic

inferred from title

reproducibility

1 reference

based on heuristic

inferred from title

Calogero Saieva

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25367072%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25367072%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Simonetta Bianchi

1

object named as

S Bianchi

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25367072%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

author name string

S Caini

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25367072%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

M Paglierani

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25367072%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

V Vezzosi

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25367072%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

G Baroni

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25367072%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

A Simoni

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25367072%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Tuscany Breast Cancer Study Group

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25367072%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

publication date

4 November 2014

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25367072%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Pathology Oncology Research

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25367072%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

21

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25367072%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25367072%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

477-485

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25367072%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

describes a project that uses

immunohistochemistry

1 reference

based on heuristic

inferred from title

https://scigraph.springernature.com/pub.10.1007/s12253-014-9852-0

0 references

Localization of the human erbB-2 gene on normal and rearranged chromosomes 17 to bands q12-21.32.

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9852-0

21 January 2018

HER2 testing: current status and future directions.

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9852-0

21 January 2018

HER2 in situ hybridization in breast cancer: clinical implications of polysomy 17 and genetic heterogeneity

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9852-0

21 January 2018

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9852-0

21 January 2018

HER2 testing in the UK: further update to recommendations

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9852-0

21 January 2018

Updated recommendations from the Canadian National Consensus Meeting on HER2/neu testing in breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9852-0

21 January 2018

Real-world performance of HER2 testing--National Surgical Adjuvant Breast and Bowel Project experience

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9852-0

21 January 2018

External Quality Assurance in Immunohistochemistry - Is It the Solution to a Complex Problem?

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9852-0

21 January 2018

Influence of slide aging on results of translational research studies using immunohistochemistry

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9852-0

21 January 2018

Does chromosome 17 centromere copy number predict polysomy in breast cancer? A fluorescence in situ hybridization and microarray-based CGH analysis

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9852-0

21 January 2018

Polysomy 17 in breast cancer: clinicopathologic significance and impact on HER-2 testing.

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9852-0

21 January 2018

Weighted kappa: nominal scale agreement with provision for scaled disagreement or partial credit

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9852-0

21 January 2018

The Measurement of Observer Agreement for Categorical Data

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9852-0

21 January 2018

Recommendations for HER2 testing in the UK.

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9852-0

21 January 2018

Implementation of External Quality Assurance Trials for Immunohistochemically Determined Breast Cancer Biomarkers in Germany

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9852-0

21 January 2018

Human epidermal growth factor receptor 2 (HER2) immunoreactivity: specificity of three pharmacodiagnostic antibodies

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9852-0

21 January 2018

Immunohistology--past, present, and future

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9852-0

21 January 2018

Practice of HER-2 immunohistochemistry in breast carcinoma in Austria

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9852-0

21 January 2018

Evaluating HER2 amplification and overexpression in breast cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9852-0

21 January 2018

Guidelines for human epidermal growth factor receptor 2 testing: biologic and methodologic considerations

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9852-0

21 January 2018

Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9852-0

21 January 2018

Genetic heterogeneity in HER2 testing in breast cancer: panel summary and guidelines

1 reference

https://pubmed.ncbi.nlm.nih.gov/25367072

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of HER-2/neu immunohistochemical assay sensitivity and scoring on formalin-fixed and paraffin-processed cell lines and breast tumors: a comparative study involving results from laboratories in 21 countries

1 reference

https://pubmed.ncbi.nlm.nih.gov/25367072

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12253-014-9852-0

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25367072%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25367072%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54311896&oldid=1878969845"